254 related articles for article (PubMed ID: 15191203)
1. Transcriptional downregulation of tight junction protein ZO-1 in active coeliac disease is reversed after a gluten-free diet.
Pizzuti D; Bortolami M; Mazzon E; Buda A; Guariso G; D'Odorico A; Chiarelli S; D'Incà R; De Lazzari F; Martines D
Dig Liver Dis; 2004 May; 36(5):337-41. PubMed ID: 15191203
[TBL] [Abstract][Full Text] [Related]
2. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
[TBL] [Abstract][Full Text] [Related]
4. Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure.
Ewert P; Aguilera S; Alliende C; Kwon YJ; Albornoz A; Molina C; Urzúa U; Quest AF; Olea N; Pérez P; Castro I; Barrera MJ; Romo R; Hermoso M; Leyton C; González MJ
Arthritis Rheum; 2010 May; 62(5):1280-9. PubMed ID: 20131287
[TBL] [Abstract][Full Text] [Related]
5. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways.
Neunlist M; Toumi F; Oreschkova T; Denis M; Leborgne J; Laboisse CL; Galmiche JP; Jarry A
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1028-36. PubMed ID: 12881224
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ZO-1 in cultured human corneal epithelial cells by a peptide (PHSRN) corresponding to the second cell-binding site of fibronectin.
Yanai R; Ko JA; Nomi N; Morishige N; Chikama T; Hattori A; Hozumi K; Nomizu M; Nishida T
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2757-64. PubMed ID: 19264897
[TBL] [Abstract][Full Text] [Related]
7. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated and treated celiac disease.
Montalto M; Cuoco L; Ricci R; Maggiano N; Vecchio FM; Gasbarrini G
Digestion; 2002; 65(4):227-33. PubMed ID: 12239464
[TBL] [Abstract][Full Text] [Related]
9. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease.
Schumann M; Günzel D; Buergel N; Richter JF; Troeger H; May C; Fromm A; Sorgenfrei D; Daum S; Bojarski C; Heyman M; Zeitz M; Fromm M; Schulzke JD
Gut; 2012 Feb; 61(2):220-8. PubMed ID: 21865402
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
11. Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.
Ojetti V; Gabrielli M; Migneco A; Lauritano C; Zocco MA; Scarpellini E; Nista EC; Gasbarrini G; Gasbarrini A
Scand J Gastroenterol; 2008; 43(2):174-7. PubMed ID: 17917999
[TBL] [Abstract][Full Text] [Related]
12. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease.
Esposito G; Cirillo C; Sarnelli G; De Filippis D; D'Armiento FP; Rocco A; Nardone G; Petruzzelli R; Grosso M; Izzo P; Iuvone T; Cuomo R
Gastroenterology; 2007 Sep; 133(3):918-25. PubMed ID: 17678654
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR
Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632
[TBL] [Abstract][Full Text] [Related]
14. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.
Carroccio A; Brusca I; Iacono G; Alessio MG; Sonzogni A; Di Prima L; Barrale M; Ottomano C; Ambrosiano G; Teresi S; D'Angelo A; Pirrone G; Cefalù B; Scalici C; La Chiusa SM
Dig Liver Dis; 2007 Sep; 39(9):818-23. PubMed ID: 17652043
[TBL] [Abstract][Full Text] [Related]
15. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease.
Ciccocioppo R; Finamore A; Ara C; Di Sabatino A; Mengheri E; Corazza GR
Am J Clin Pathol; 2006 Apr; 125(4):502-11. PubMed ID: 16627260
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
17. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
Cellier C; Cervoni JP; Patey N; Leborgne M; Marteau P; Landi B; Cerf-Bensussan N; Barbier JP; Brousse N
Am J Gastroenterol; 1998 Sep; 93(9):1527-30. PubMed ID: 9732937
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction.
Demaude J; Salvador-Cartier C; Fioramonti J; Ferrier L; Bueno L
Gut; 2006 May; 55(5):655-61. PubMed ID: 16299034
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin.
Youakim A; Ahdieh M
Am J Physiol; 1999 May; 276(5):G1279-88. PubMed ID: 10330020
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression of claudins in active ulcerative colitis.
Oshima T; Miwa H; Joh T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S146-50. PubMed ID: 19120888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
